Eagle Asset Management Inc Integra Lifesciences Holdings Corp Transaction History

Eagle Asset Management Inc

$16.7 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$23.14 - $34.72 $1.69 Million - $2.53 Million	-72,889 Reduced 22.87%	245,841 $7.16 Million
Q1 2024 May 09, 2024	BUY	$33.4 - $45.2 $699,028 - $945,990	20,929 Added 7.03%	318,730 $11.3 Million
Q4 2023 Feb 12, 2024	BUY	$34.21 - $44.59 $410,246 - $534,723	11,992 Added 4.2%	297,801 $13 Million
Q3 2023 Nov 13, 2023	BUY	$37.8 - $45.97 $380,608 - $462,871	10,069 Added 3.65%	285,809 $10.9 Million
Q2 2023 Aug 09, 2023	BUY	$37.95 - $58.98 $2.22 Million - $3.45 Million	58,420 Added 26.88%	275,740 $11.3 Million
Q1 2023 May 08, 2023	BUY	$52.61 - $60.49 $4.27 Million - $4.91 Million	81,145 Added 59.59%	217,320 $12.5 Million
Q4 2022 Feb 14, 2023	SELL	$42.17 - $58.6 $108,081 - $150,191	-2,563 Reduced 1.85%	136,175 $7.64 Million
Q3 2022 Nov 07, 2022	BUY	$42.28 - $57.17 $1.9 Million - $2.57 Million	44,996 Added 48.0%	138,738 $5.88 Million
Q2 2022 Aug 10, 2022	SELL	$53.86 - $66.52 $10,664 - $13,170	-198 Reduced 0.21%	93,742 $5.06 Million
Q1 2022 May 12, 2022	SELL	$62.86 - $69.24 $343,152 - $377,981	-5,459 Reduced 5.49%	93,940 $6.04 Million
Q4 2021 Feb 11, 2022	SELL	$62.47 - $73.25 $8.73 Million - $10.2 Million	-139,792 Reduced 58.44%	99,399 $6.8 Million
Q3 2021 Nov 10, 2021	SELL	$64.97 - $76.19 $4.26 Million - $4.99 Million	-65,544 Reduced 21.51%	239,191 $16.4 Million
Q2 2021 Aug 11, 2021	BUY	$66.79 - $76.63 $156,221 - $179,237	2,339 Added 0.77%	304,735 $20.8 Million
Q1 2021 May 14, 2021	BUY	$62.63 - $71.15 $1.8 Million - $2.05 Million	28,808 Added 10.53%	302,396 $20.6 Million
Q4 2020 Feb 12, 2021	SELL	$43.31 - $66.55 $3.24 Million - $4.97 Million	-74,702 Reduced 21.45%	273,588 $17.8 Million
Q3 2020 Nov 12, 2020	BUY	$43.33 - $51.72 $538,808 - $643,138	12,435 Added 3.7%	348,290 $16.2 Million
Q2 2020 Aug 12, 2020	BUY	$41.42 - $55.57 $1.49 Million - $1.99 Million	35,891 Added 11.97%	335,855 $15.6 Million
Q1 2020 May 11, 2020	BUY	$36.67 - $61.04 $1.48 Million - $2.47 Million	40,418 Added 15.57%	299,964 $13.4 Million
Q4 2019 Feb 07, 2020	BUY	$55.73 - $62.49 $2.33 Million - $2.61 Million	41,750 Added 19.17%	259,546 $15.1 Million
Q3 2019 Nov 04, 2019	SELL	$53.29 - $64.59 $203,887 - $247,121	-3,826 Reduced 1.73%	217,796 $13.1 Million
Q2 2019 Aug 05, 2019	SELL	$46.45 - $55.85 $189,562 - $227,923	-4,081 Reduced 1.81%	221,622 $12.4 Million
Q1 2019 May 01, 2019	BUY	$42.97 - $57.33 $58,396 - $77,911	1,359 Added 0.61%	225,703 $12.6 Million
Q4 2018 Feb 11, 2019	BUY	$42.62 - $64.51 $399,775 - $605,103	9,380 Added 4.36%	224,344 $10.1 Million
Q3 2018 Nov 08, 2018	BUY	$57.63 - $65.87 $2.61 Million - $2.99 Million	45,350 Added 26.74%	214,964 $14.2 Million
Q2 2018 Aug 07, 2018	BUY	$54.05 - $67.23 $432,075 - $537,436	7,994 Added 4.95%	169,614 $10.9 Million
Q1 2018 May 09, 2018	SELL	$46.55 - $57.38 $68,707 - $84,692	-1,476 Reduced 0.9%	161,620 $8.94 Million
Q4 2017 Feb 09, 2018	BUY	$46.22 - $51.77 $103,394 - $115,809	2,237 Added 1.39%	163,096 $7.89 Million
Q3 2017 Nov 09, 2017	BUY	$47.8 - $53.63 $7.69 Million - $8.63 Million	160,859	160,859 $8.16 Million

Others Institutions Holding IART

# of Institutions

241

Shares Held

75.3M

Call Options Held

585K

Put Options Held

21.3K

Black Rock Inc. New York, NY

11.3M
Shares

$249 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.74M
Shares

$172 Million
0.0% of portfolio
Morgan Stanley New York, NY

5.26M
Shares

$116 Million
0.01% of portfolio
Eaton Vance Management Boston, MA

4.22M
Shares

$93.4 Million
0.26% of portfolio
Fuller & Thaler Asset Management, Inc. San Mateo, CA

3.97M
Shares

$87.9 Million
0.29% of portfolio

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Account